Maimónides Biomedical Research Institute Of Córdoba
Clinical trials sponsored by Maimónides Biomedical Research Institute Of Córdoba, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test after transplant may flag hidden virus risk Results expected Jun 2027 (estimated)
-
Heart failure patients may boost fitness with online lifestyle program
Symptom relief Not yet recruitingThis study tests whether a 6-month digital education program—with short videos on exercise, healthy eating, and stress management—can improve exercise capacity and quality of life in adults with heart failure and overweight or obesity. Fifty-two participants will be randomly assi…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple injection make hysteroscopy Pain-Free?
Symptom relief Not yet recruitingThis study tests whether injecting a local anesthetic (mepivacaine) into the ligaments around the cervix can reduce pain during an outpatient hysteroscopy. About 70 women who have never had a hysteroscopy will be randomly assigned to receive either the anesthetic or a placebo. Th…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Symptom relief
Last updated Jun 26, 2026 18:10 UTC
-
CrossFit for kids: a new way to boost strength and Self-Esteem?
Knowledge-focused Not yet recruitingThis study looks at whether an 8-week CrossFit program can make kids aged 7 to 11 stronger, fitter, and happier. Thirty children will be split into two groups: one does CrossFit twice a week, the other continues their normal routine. Researchers will measure physical changes like…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Blood test after transplant may flag hidden virus risk
Knowledge-focused Not yet recruitingThis study follows 123 stem cell transplant patients to see if measuring their immune response to CMV after stopping a preventive drug (letermovir) can predict late infections. Participants will have regular blood tests up to 200 days after transplant. The goal is to learn whethe…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC